IMV INC.

IMV
Delayed Quote. Delayed  - 11/24 04:00:00 pm
4.46CAD -2.83%
Prev.4.5900
Open4.6500
High4.6600
Low4.4100
Volume144 705
Latest news
11/16
11/13
11/13
11/12
Chart IMV INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance5,267,946,87
Spread/Res.-15%-44%-35%
Spread/Supp.7,7%21%15%
Support4,143,683,87
Financials
Sales 2020 0,22 M 0,17 M 0,17 M
Net income 2020 -31,9 M -24,5 M -24,5 M
Net Debt 2020 - - -
P/E ratio 2020 -8,34x
Yield 2020 -
Capitalization 299 M 230 M 230 M
Capi. / Sales 2020 1 379x
Capi. / Sales 2021 254x
Nbr of Employees 62
Free-Float 99,4%
Company
IMV Inc. is a clinical stage biopharmaceutical company focused on developing cancer immunotherapies and vaccines against infectious diseases, including coronavirus disease 2019 (COVID-19). The Company develops cancer-targeted immunotherapies and vaccines based on the Company’s platform, DPX. The...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-12-01 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 7,91 CAD
Last Close Price 4,46 CAD
Spread / Highest target 124%
Spread / Average Target 77,3%
Spread / Lowest Target -11,9%